SCL Biosciences seeks potential partners who can join us and be part of one of advanced custom antibody development and allied initiative.

We offer following:

• IP Protection: SCL Biosciences will sign a confidentiality agreement with our customers to ensure the protection of all project related information.  All staff members assigned to the project will sign a confidentiality agreement to maintain confidentiality.
  
  
• Ownership: Once developed, we shall ship the hybridomas/antibodies to our customers, and all products associated with the project shall become the exclusive property of our customers. SCL Biosciences shall make no claim to ownership.
  
  
• Documentation: Our documentation is accurate and well organized. We share immunization protocols, ELISA protocols and ELISA graphs with our customers. This information will be provided at the end of the project, absolutely free of cost.
  
  
• Project updates: Customer will be informed about the project status regularly. Our standard is milestone based; however some of our customers choose a short time interval.
  
  
• Interaction made easy: We assign a scientist as your contact person, and you will be able to reach us with out any delay.
  
  
• Flexibility: We have developed a very successful antibody development protocol. However if the customer wants a particular protocol we are always ready to incorporate any changes.